By Chris Wack
NLS Pharmaceutics shares were down 35% to 32 cents after the company said it is conducting an ongoing process to explore strategic alternatives to maximize shareholder value, and plans to cut 50% of its work force.
The stock hit its 52-week low of 26 cents earlier in the session Thursday, and is down 38% in the past 12 months.
…
Read the full article here